Modern Strategy for Preclinical Pharmaceutical R&D: Towards the Virtual Research CompanyISBN: 978-0-471-97117-7
Hardcover
228 pages
October 1997
 This is a Print-on-Demand title. It will be printed specifically to fill your order. Please allow an additional 10-15 days delivery time. The book is not returnable.
|
||||||
David Cavalla is an expert on secondary uses for existing drugs, or drug repurposing. He currrently operates through his consultancy, Numedicus Ltd, having worked in drug repurposing for 15 years. Previously he was CEO of Arachnova, and prior to that held various senior positions in pharmaceutical drug discovery at GSK and Napp Research Centre. He has written widely on drug discovery strategy, and is the author of 70 published papers and patents.
Related Titles
General Pharmacology & Pharmaceutical Medicine
.png){kind=small}
Join An E-mail ListLearn about the latest products, events, offers and content. |
